Investors Watch List: Johnson & Johnson (NYSE:JNJ), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), NanoString Technologies, Inc. (NASDAQ:NSTG), OvaScience (NASDAQ:OVAS), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Johnson & Johnson (NYSE:JNJ) was the first major company from the drug manufacturing industry to post impressive second-quarter earnings. The NYSE ARCA Pharmaceutical Index is up almost 20.1% in the last year. So far in 2014, the index increased10%. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 21.20% and weekly performance is 2.13%. On last trading day company shares ended up $104.19. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 1.19%.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) had a roller coaster week. The Boston-based biotech on Monday announced it was discontinuing US sales of its hepatitis C drug Incivek. But shares rallied later in the week, posting the biggest gain in the S&P 500 on Thursday — in part because of a narrower-than expected loss. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares fell -2.53% in last trading session and ended the day at $88.99. VRTX Gross Margin is 93.80% and its return on assets is -20.50%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) quarterly performance is 25.02%.

NanoString Technologies (NASDAQ:NSTG) Director Charles P. Waite, Jr. sold 18,557 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $12.05, for a total value of $223,611.85. On 21 August, NanoString Technologies, Inc. (NASDAQ:NSTG) shares moved up 0.17% and was closed at $11.49. NSTG EPS growth in last 5 year was 33.60%. NanoString Technologies, Inc. (NASDAQ:NSTG) year to date (YTD) performance is -33.35%.

Ovascience Inc. (NASDAQ:OVAS) issued its quarterly earnings data on Thursday, 07 Aug 2014. The company reported ($0.42) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.45) by $0.03. On the ratings front, analysts at HC Wainwright reiterated a “buy” rating on shares of Ovascience in a research note on Monday, May 12th. OvaScience, Inc. (NASDAQ:OVAS) ended the last trading day at $11.24. Company weekly volatility is calculated as 4.02%and price to cash ratio as 3.05. OvaScience, Inc. (NASDAQ:OVAS) showed a weekly performance of -6.72%.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s Hacksell Uli sold 15,000 shares at $22.89 per share. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is focused primarily on the commercialization and development of small molecule drugs for the treatment of central nervous system illnesses. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares fell -2.95% in last trading session and ended the day on $22.02. ACAD return on assets is -22.10%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) quarterly performance is 12.52%.